Point of care COVID-19 tests using small, portable devices are not yet widely available. While there is great hope that these tests will be inexpensive and easy to use, many are currently in development and others have been proven to have more variability and lower accuracy than the gold standard PCR (polymerase chain reaction) COVID-19 test, which is currently used by CHL.
- CHL will study, validate, adopt and provide a platform to deploy any novel testing technology that helps keep Canadians safe, including point of care COVID-19 tests.
- CHL will embrace and deploy any new test that challenges the speed, accuracy, and cost of PCR, should one emerge. Our research into new tests is enabled by our partnerships with many Canadian universities leading to impartial data-driven decisions.
- CHL is invested in results for all Canadians.